IFN[gamma] in the Treatment of a Patient With IL12R[beta]1 Deficiency and BCGosis

A A Alangari; F Al-Zamil; A Al-Mazrou; S Awadallah; A Kambal; J Casanova

doi:10.1016/j.jaci.2009.12.290

Back

IFN[gamma] in the Treatment of a Patient With IL12R[beta]1 Deficiency and BCGosis

Journal article

Peer reviewed

IFN[gamma] in the Treatment of a Patient With IL12R[beta]1 Deficiency and BCGosis

A A Alangari, F Al-Zamil, A Al-Mazrou, S Awadallah, A Kambal and J Casanova

Journal of allergy and clinical immunology, Vol.125(2), p.AB74

01/02/2010

DOI: https://doi.org/10.1016/j.jaci.2009.12.290

Abstract

Medical research

Medical treatment

In a patient with IL12RÎ²1 deficiency, IFNÎ³ at a dose of 200 mcg/m2, but not at lower dosages, was found to have a noticeable clinical effect with no additional adverse effects.

Metrics

1 Record Views

Details

Title: IFN[gamma] in the Treatment of a Patient With IL12R[beta]1 Deficiency and BCGosis
Creators - without role: A A Alangari
F Al-Zamil
A Al-Mazrou
S Awadallah
A Kambal
J Casanova
Publication Details: Journal of allergy and clinical immunology, Vol.125(2), p.AB74
Publisher: Elsevier Limited
Identifiers: 9951471808331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article